Dignitana is a Swedish medical technology company publicly traded on Nasdaq First North Growth Market. Company headquarters are in Lund, Sweden and operations are based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy.
The company develops, produces and markets The DigniCap Scalp Cooling System. It is a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy to improve well-being and quality of life. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. In 2017, Dignitana received an expanded clearance from the FDA, allowing DigniCap to be used by patients receiving chemotherapy to treat solid tumors from breast cancer as well as those from prostate, ovarian, uterine, lungs and other tissues.
Cancer is a leading cause of death worldwide and the number of people who develop cancer is continuing to increase. According to the World Health Organization (WHO), 14.1 million people are annually diagnosed with cancer. One of the most common therapies for cancer is chemotherapy. Globally an estimated 20,000 clinics offer chemotherapy, providing a total of over ten million chemotherapy treatments with per year.
Chemotherapy has several unpleasant side effects, with hair loss being the most visible and often identified as the most distressing side effect as well. Physicians estimate that approximately ten percent of patients decline the prescribed chemotherapy out of fear of losing their hair.
Dignitana’s system DigniCap is primarily used today in the treatment of breast cancer, the most common type of cancer in women worldwide with the World Cancer Research Fund reporting over 1.7 million diagnosed cases annually. Dignitana estimates that 60 percent of breast cancer patients can be treated with the DigniCap system.
The full company description for the original listing on NASDAQ OMX First North in 2011 can be downloaded HERE.
Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.
10925 Estate Lane, Suite 185
Dallas, TX 75238
226 60 Lund, Sweden
+46 46 16 30 90
Corso di Porta Nuova, 46
20121 Milan, Italy